Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Drug Manufacturers — General

Categories: @vaccine-makers   

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Website: jnj.com


  • Good financial results growth rate 42.8% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (16.4%)
  • Dividend yield for the last twelve months 2.2%
  • Free cash flow yield -1.5% (LTM)
  • Share price is 71.5% higher than minimum and -1.1% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (17.0x vs 18.7x)
  • Fundamental value created in LTM (estimate)

Key Financials (Download financials)

Ticker: JNJ
Share price, USD:  (-0.4%)243.61
year average price 178.58  


year start price 156.15 2025-02-14

min close price 146.36 2025-05-14

max close price 244.55 2026-02-12

current price 243.61 2026-02-13
Common stocks: 2 631 399 832

Dividend Yield:  2.2%
FCF Yield LTM: -1.5%
EV / LTM EBITDA: 17.0x
EV / EBITDA annualized: 17.8x
Last revenue growth (y/y):  +6.8%
Last growth of EBITDA (y/y):  +78.8%
Historical revenue growth:  +2.3%
Historical growth of EBITDA:  +30.5%
EV / Sales: 7.2x
Margin (EBITDA LTM / Revenue): 42.2%

Target EV / EBITDA (hist percentile): 18.7x
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 633 799
Net Debt ($m): 27 233
EV (Enterprise Value): 661 032
EBITDA LTM (млн $): 38 890
EV / LTM EBITDA: 17.0x
Price to Book: 8.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2026-02-08fool.com

What is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill.

2026-02-06businesswire.com

Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium

2026-02-03forbes.com

What's Behind The 50% Surge In JNJ Stock?

2026-02-03globenewswire.com

Johnson & Johnson Launches the First and Only Daily Disposable Multifocal Toric Contact Lens for Astigmatic Patients with Presbyopia in United Kingdom and Ireland

2026-02-01defenseworld.net

Winnow Wealth LLC Has $1.71 Million Position in Johnson & Johnson $JNJ

2026-01-30fool.com

This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy?

2026-01-30seekingalpha.com

Johnson & Johnson: Fraud Claim Dismissal Today Is Not A Sign Talc Litigation Is Over

2026-01-29reuters.com

US judge tosses lawsuit accusing J&J of fraud over talc bankruptcy strategy

2026-01-28zacks.com

Should You Stay Invested in J&J Stock After Q4 Beat & Solid Guidance?

2026-01-28seekingalpha.com

Johnson & Johnson: Strong Momentum Heading Into 2026
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q4 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-12-31 2025-09-28 2025-06-29 2024-12-29 2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-01-02 2020-12-31
symbol JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406
filingDate 2025-12-31 2025-02-13 2024-02-16 2023-02-16 2022-02-17 2021-02-22
acceptedDate 2025-12-30 19:00:00 2025-10-22 16:04:17 2025-07-24 16:04:24 2025-02-13 16:07:39 2024-10-23 16:02:27 2024-07-25 16:02:29 2024-05-01 07:09:36 2024-02-16 16:12:22 2023-10-27 16:11:34 2023-07-31 16:06:04 2023-04-28 16:07:02 2023-02-16 16:01:53 2022-10-27 16:02:59 2022-02-17 16:06:50 2021-02-22 16:36:14
fiscalYear 2025 2024 2023 2022 2021 2020
period FY Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 94 193M 23 993M 23 743M 88 821M 22 471M 22 447M 21 383M 85 159M 21 345M 25 530M 24 746M 79 990M 23 791M 78 740M 82 584M
costOfRevenue 25 635M 7 303M 7 628M 27 471M 6 963M 6 869M 6 511M 26 553M 6 504M 8 212M 8 395M 24 596M 7 807M 23 402M 28 427M
grossProfit 68 558M 16 690M 16 115M 61 350M 15 508M 15 578M 14 872M 58 606M 14 841M 17 318M 16 351M 55 394M 15 984M 55 338M 54 157M
researchAndDevelopmentExpenses 14 665M 3 672M 3 516M 17 232M 4 952M 3 440M 3 542M 15 085M 3 442M 3 829M 3 612M 14 135M 3 597M 14 277M 12 340M
generalAndAdministrativeExpenses 23 676M 5 922M 5 789M 21 969M 0 5 481M 5 057M 20 112M 0 0 5 738M 20 246M 0 20 118M 22 084M
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 400M 0 0 0 0
sellingGeneralAndAdministrativeExpenses 23 676M 5 922M 5 789M 21 969M 5 278M 5 481M 5 057M 20 112M 5 400M 6 665M 6 138M 20 246M 6 089M 20 118M 22 084M
otherExpenses 4 621M 0 0 0 0 400M 200M 0 400M 60M -7 228M 0 0 0 0
operatingExpenses 42 962M 9 594M 9 305M 39 201M 10 427M 8 921M 8 599M 35 197M 8 842M 10 494M 9 750M 34 381M 9 686M 34 395M 34 424M
costAndExpenses 68 597M 16 897M 16 933M 66 672M 17 210M 15 790M 15 110M 61 750M 15 346M 18 706M 18 145M 58 977M 17 493M 57 797M 62 851M
netInterestIncome 85M 577M 489M 214M -130M -90M
interestIncome 85M 227M 260M 1 332M 292M 395M 364M 1 261M 374M 369M 235M 490M 150M 53M 111M
interestExpense 0 18M 308M 755M 193M 270M 155M 772M 264M 207M 215M 276M 51M 183M 201M
depreciationAndAmortization 0 1 777M 1 943M 7 339M 1 846M 1 782M 1 815M 7 486M 1 829M 1 934M 1 880M 6 970M 1 685M 7 390M 7 231M
ebitda 32 581M 9 288M 8 742M 24 781M 5 484M 8 476M 8 648M 23 320M 7 828M 6 969M 6 731M 26 605M 7 558M 26 751M 23 929M
ebit 32 581M 17 442M 15 834M 19 635M 19 361M 16 698M
nonOperatingIncomeExcludingInterest -6 985M 4 707M 7 575M 1 378M 1 582M 3 035M
operatingIncome 25 596M 7 096M 6 810M 22 149M 2 694M 7 499M 6 833M 23 409M 5 999M 6 847M 6 621M 21 013M 6 298M 20 943M 19 733M
totalOtherIncomeExpensesNet 6 985M 397M -319M -5 462M 644M -909M -2 189M -8 347M -782M -85M -7 358M -1 654M -476M -1 765M -3 236M
incomeBeforeTax 32 581M 7 493M 6 491M 16 687M 3 338M 5 748M 3 714M 15 062M 5 217M 6 762M -737M 19 359M 5 822M 19 178M 16 497M
incomeTaxExpense 5 777M 2 341M 954M 2 621M 644M 1 062M 459M 1 736M 908M 1 618M -669M 2 989M 1 364M 1 377M 1 783M
netIncomeFromContinuingOperations 26 804M 14 066M 13 326M 16 370M 17 801M 14 714M
netIncomeFromDiscontinuedOperations 0 0 21 827M 1 571M 3 077M 0
otherAdjustmentsToNetIncome 0 0 0 0 0 0
netIncome 26 804M 5 152M 5 537M 14 066M 2 694M 4 686M 3 255M 35 153M 26 028M 5 144M -68M 17 941M 4 458M 20 878M 14 714M
netIncomeDeductions 0 0 0 0 0 0
bottomLineNetIncome 26 804M 14 066M 35 153M 17 941M 20 878M 14 714M
eps 0 2.12 2.29 5.84 1.12 1.95 1.35 13.88 10.81 1.98 -0.026 6.83 1.696 7.93 5.59
epsDiluted 11.03 5.79 13.72 6.73 7.81 5.51
weightedAverageShsOut 2 429M 2 429M 2 419M 2 407M 2 407M 2 407M 2 408M 2 534M 2 407M 2 599M 2 606M 2 614M 2 617M 2 629M 2 633M
weightedAverageShsOutDil 2 429M 2 429M 2 419M 2 429M 2 428M 2 422M 2 430M 2 560M 2 550M 2 626M 2 606M 2 664M 2 661M 2 674M 2 671M
fillingDate 2025-10-22 2025-07-24 2024-10-23 2024-07-25 2024-05-01 2023-10-27 2023-07-31 2023-04-28 2022-10-27
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
grossProfitRatio 0.696 0.679 0.69 0.694 0.696 0.695 0.678 0.661 0.672
ebitdaratio 0.387 0.368 0.244 0.413 0.404 0.367 0.273 0.272 0.318
operatingIncomeRatio 0.296 0.287 0.12 0.334 0.32 0.281 0.268 0.268 0.265
incomeBeforeTaxRatio 0.312 0.273 0.149 0.256 0.174 0.244 0.265 -0.03 0.245
netIncomeRatio 0.215 0.233 0.12 0.209 0.152 1.219 0.201 -0.003 0.187
epsdiluted 2.12 2.29 1.11 1.93 1.34 10.21 1.96 -0.026 1.68
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-28 2025-06-29 2024-12-29 2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-01-02 2021-01-03
symbol JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406
fillingDate 2025-10-22 2025-07-24 2024-10-23 2024-07-25 2024-05-01 2023-10-27 2023-07-31 2023-04-28 2022-10-27
acceptedDate 2025-10-22 16:04:17 2025-07-24 16:04:24 2025-02-13 16:07:39 2024-10-23 16:02:27 2024-07-25 16:02:29 2024-05-01 07:09:36 2024-02-16 16:12:22 2023-10-27 16:11:34 2023-07-31 16:06:04 2023-04-28 16:07:02 2023-02-16 16:01:53 2022-10-27 16:02:59 2022-02-17 16:06:50 2021-02-22 16:36:14
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 18 231M 18 577M 24 105M 19 980M 24 878M 25 473M 21 859M 19 728M 21 183M 19 170M 12 889M 11 355M 14 487M 13 985M
shortTermInvestments 331M 303M 417M 317M 597M 745M 1 068M 3 783M 7 322M 5 443M 9 392M 22 724M 17 121M 11 200M
cashAndShortTermInvestments 18 562M 18 880M 24 522M 20 297M 25 475M 26 218M 22 927M 23 511M 28 505M 24 613M 22 281M 34 079M 31 608M 25 185M
netReceivables 17 611M 17 846M 18 927M 16 174M 15 794M 14 946M 14 873M 14 798M 16 777M 16 350M 16 915M 15 890M 18 984M 13 576M
inventory 14 146M 13 412M 12 444M 12 603M 12 169M 11 383M 11 181M 11 198M 12 888M 12 809M 10 268M 11 675M 10 387M 9 344M
otherCurrentAssets 4 292M 4 360M 0 4 175M 4 379M 4 455M 0 4 196M 2 397M 10 616M 5 830M 3 592M -3 701M 0
totalCurrentAssets 54 611M 54 498M 55 893M 53 249M 57 817M 57 002M 53 495M 53 703M 60 567M 64 388M 55 294M 65 236M 60 979M 51 237M
propertyPlantEquipmentNet 53 375M 21 949M 20 518M 20 479M 19 748M 19 632M 19 898M 18 821M 20 576M 20 174M 17 982M 18 152M 18 962M 18 766M
goodwill 48 048M 48 117M 44 200M 44 799M 44 250M 36 616M 36 558M 36 124M 45 440M 45 575M 36 047M 33 383M 35 246M 36 393M
intangibleAssets 48 737M 49 835M 37 618M 39 490M 39 725M 34 286M 34 175M 35 021M 46 246M 47 448M 38 489M 40 336M 46 392M 53 402M
goodwillAndIntangibleAssets 96 785M 97 952M 81 818M 84 289M 83 975M 70 902M 70 733M 71 145M 91 686M 93 023M 74 536M 73 719M 81 638M 89 795M
longTermInvestments 0 0 0 0 1 143M 0 0 4 023M 0 0 0 0 0 0
taxAssets 6 666M 6 801M 10 461M 9 349M 9 004M 10 305M 9 279M 9 259M 8 779M 8 817M 8 947M 9 392M 10 223M 8 534M
otherNonCurrentAssets -18 621M 12 189M 11 414M 10 921M 9 401M 14 125M 14 153M 9 110M 10 078M 9 567M 30 619M 8 625M 10 216M 6 562M
totalNonCurrentAssets 138 205M 138 891M 124 211M 125 038M 123 271M 114 964M 114 063M 112 358M 131 119M 131 581M 132 084M 109 888M 121 039M 123 657M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 192 816M 193 389M 180 104M 178 287M 181 088M 171 966M 167 558M 166 061M 191 686M 195 969M 187 378M 175 124M 182 018M 174 894M
accountPayables 9 625M 9 464M 10 311M 8 954M 8 848M 8 174M 9 632M 8 355M 10 443M 9 909M 9 889M 10 153M 11 055M 9 505M
shortTermDebt 6 387M 11 526M 5 983M 4 462M 9 855M 8 550M 3 451M 3 870M 11 701M 17 979M 12 756M 4 424M 3 766M 2 631M
taxPayables 1 928M 1 665M 3 772M 4 834M 4 309M 3 318M 2 993M 2 899M 2 687M 4 266M 2 220M 1 986M 1 112M 1 392M
deferredRevenue 0 0 0 0 4 309M 0 0 2 899M 2 687M 0 0 0 0 0
otherCurrentLiabilities 32 929M 31 525M 4 126M 33 509M 30 921M 28 683M 3 993M 29 246M 29 339M 32 485M 6 639M 30 966M 3 586M 3 484M
totalCurrentLiabilities 50 869M 54 180M 50 321M 51 759M 53 933M 48 725M 46 282M 44 370M 54 170M 60 373M 55 802M 45 543M 45 226M 42 493M
longTermDebt 39 408M 39 235M 30 651M 31 289M 31 636M 25 082M 25 881M 26 051M 33 901M 34 928M 26 886M 27 603M 29 985M 32 635M
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 8 997M 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 5 988M 3 799M 2 448M 2 952M 2 635M 3 172M 3 193M 2 623M 3 627M 4 417M 3 991M 4 946M 7 487M 7 214M
otherNonCurrentLiabilities 17 274M 17 702M 25 194M 22 129M 21 346M 24 967M 23 428M 21 789M 14 582M 25 382M 23 895M 40 405M 25 297M 29 274M
totalNonCurrentLiabilities 62 670M 60 736M 58 293M 56 370M 55 617M 53 221M 52 502M 50 463M 61 107M 64 727M 54 772M 54 982M 62 769M 69 123M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilities 113 539M 114 916M 108 614M 108 129M 109 550M 101 946M 98 784M 94 833M 115 277M 125 100M 110 574M 100 525M 107 995M 111 616M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 3 120M 3 120M 3 120M 3 120M 3 120M 3 120M 3 120M 3 120M 3 120M 3 120M 3 120M 3 120M 3 120M 3 120M
retainedEarnings 167 281M 165 371M 155 791M 155 179M 155 360M 153 378M 153 843M 152 536M 129 381M 124 558M 128 345M 127 917M 123 060M 113 890M
accumulatedOtherComprehensiveIncomeLoss -15 237M -14 305M -11 741M -12 522M -11 253M -10 768M -12 527M -8 780M -13 135M -12 626M -12 967M -15 292M -13 058M -15 242M
othertotalStockholdersEquity -75 887M -75 713M -75 619M -75 689M -75 710M -75 648M -44 217M -44 183M -41 146M
totalStockholdersEquity 79 277M 78 473M 71 490M 70 158M 71 538M 70 020M 68 774M 71 228M 75 149M 70 869M 76 804M 74 599M 74 023M 63 278M
totalEquity 79 277M 78 473M 71 490M 70 158M 71 538M 70 020M 68 774M 71 228M 76 409M 70 869M 76 804M 74 599M 74 023M 63 278M
totalLiabilitiesAndStockholdersEquity 192 816M 193 389M 178 287M 181 088M 171 966M 166 061M 191 686M 195 969M 175 124M
minorityInterest 0 0 0 0 0 0 0 0 1 260M 0 0 0 0 0
totalLiabilitiesAndTotalEquity 192 816M 193 389M 180 104M 178 287M 181 088M 171 966M 167 558M 166 061M 191 686M 195 969M 187 378M 175 124M 182 018M 174 894M
totalInvestments 331M 303M 417M 317M 597M 745M 1 068M 7 806M 7 322M 5 443M 9 392M 22 724M 17 121M 11 200M
totalDebt 45 795M 50 761M 36 634M 35 751M 41 491M 33 632M 29 332M 29 921M 45 602M 52 907M 39 642M 32 027M 33 751M 35 266M
netDebt 27 564M 32 184M 12 529M 15 771M 16 613M 8 159M 7 473M 10 193M 24 419M 33 737M 26 753M 20 672M 19 264M 21 281M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-13 2024-02-16 2023-02-16 2022-02-17 2021-02-22
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 14 842M 14 873M 14 039M 15 283M 13 576M
otherReceivables 4 085M 0 2 876M 3 701M 0
prepaids 0 4 514M 0 3 701M 3 132M
totalPayables 14 083M 12 625M 12 109M 12 167M 10 897M
otherPayables 3 772M 2 993M 2 220M 1 112M 1 392M
accruedExpenses 26 129M 26 213M 24 298M 25 707M 25 481M
capitalLeaseObligationsCurrent 0 0 0 0 0
capitalLeaseObligationsNonCurrent 0 0 0 0 0
treasuryStock -75 680M -75 662M -41 694M -39 099M -38 490M
additionalPaidInCapital 0 153 843M 128 345M 123 060M 0
otherTotalStockholdersEquity 0 -153 843M -128 345M -123 060M 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-28 2025-06-29 2024-12-29 2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-01-02 2021-01-03
symbol JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ JNJ
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406 200 406
fillingDate 2025-10-22 2025-07-24 2024-10-23 2024-07-25 2024-05-01 2023-10-27 2023-07-31 2023-04-28 2022-10-27
acceptedDate 2025-10-22 16:04:17 2025-07-24 16:04:24 2025-02-13 16:07:39 2024-10-23 16:02:27 2024-07-25 16:02:29 2024-05-01 07:09:36 2024-02-16 16:12:22 2023-10-27 16:11:34 2023-07-31 16:06:04 2023-04-28 16:07:02 2023-02-16 16:01:53 2022-10-27 16:02:59 2022-02-17 16:06:50 2021-02-22 16:36:14
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 5 152M 5 537M 14 066M 2 694M 4 686M 3 255M 13 326M 4 309M 5 144M -68M 17 941M 4 458M 20 878M 14 714M
depreciationAndAmortization 1 777M 1 943M 7 339M 1 846M 1 782M 1 815M 7 486M 1 829M 1 934M 1 880M 6 970M 1 685M 7 390M 7 231M
deferredIncomeTax 2 218M 825M -2 183M 90M -695M -1 562M -4 194M 560M -799M -1 543M -1 663M -139M -2 079M -1 141M
stockBasedCompensation 347M 410M 1 176M 295M 341M 302M 1 162M 296M 382M 306M 1 138M 281M 1 135M 1 005M
changeInWorkingCapital 15 945M -4 921M 1 837M 1 829M -452M -338M 2 507M -602M -2 401M 2 263M -4 011M -30M -4 238M 2 690M
accountsReceivables 111M -1 357M -406M -96M -884M -279M -624M -252M -545M -54M -1 290M -205M -2 402M 774M
inventory -748M -510M -1 128M -299M -391M -348M -1 323M -706M -217M -524M -2 527M -620M -1 248M -265M
accountsPayables 1 997M 1 240M 1 621M 0 2 932M -2 483M 2 346M 1 725M 0 -2 572M 1 098M 0 2 437M 5 141M
otherWorkingCapital 14 585M -4 294M 1 750M 2 224M -2 109M 2 772M 2 108M -1 369M -1 639M 3 150M -1 292M 795M -3 025M -2 960M
otherNonCashItems -16 270M 84M 2 031M 1 239M 2 219M 7 227M 2 504M 1 097M -78M 419M 819M 29M 324M -963M
netCashProvidedByOperatingActivities 9 169M 3 878M 24 266M 7 993M 5 633M 3 657M 22 791M 7 489M 4 182M 3 257M 21 194M 6 284M 23 410M 23 536M
investmentsInPropertyPlantAndEquipment -1 157M -1 043M -4 424M -1 836M -976M -807M -4 543M -967M -1 124M -863M -4 009M -952M -3 652M -3 347M
acquisitionsNet -1 000 000 -14 458M -15 146M -338M -12 633M -1 601M 0 121M 0 252M -17 652M 1 000 000 -60M -7 323M
purchasesOfInvestments 2 438M -2 864M -1 726M -280M -554M -630M -10 906M -293M -6 712M -3 774M -32 384M -9 105M -30 394M -21 089M
salesMaturitiesOfInvestments 489M 735M 2 462M 466M 727M 979M 19 390M 3 910M 4 111M 7 766M 41 609M 8 690M 25 006M 12 137M
otherInvestingActivites -2 311M -634M -1 140M -251M 1 595M -230M -51M -66M -335M
netCashUsedForInvestingActivites -542M -18 264M -3 128M -13 687M -464M 2 541M -3 776M 3 315M -1 701M
debtRepayment -7 109M -2 376M -7 401M 11 543M -4 374M -15 468M -8 224M -5 888M -2 608M
commonStockIssued -4 029M 107M 0 0 195M 8 700M 5 633M -11M 0
commonStockRepurchased 0 0 -2 432M -539M -136M -1 475M -5 054M -920M -381M -3 537M -6 035M -2 165M -3 456M -3 221M
dividendsPaid -3 132M -3 129M -2 985M -2 985M -2 869M -2 871M -3 092M -2 942M -2 970M
otherFinancingActivites 5 343M -267M 1 043M -878M 321M -758M 73M 18 516M 3 818M
netCashUsedProvidedByFinancingActivities -8 927M -5 665M -9 882M 7 544M 546M -11 317M -5 991M 6 138M -3 925M
effectOfForexChangesOnCash -46M 154M -289M 119M -85M -125M -112M -168M -97M 28M -312M -286M -178M 89M
netChangeInCash -346M -19 897M 2 246M -4 898M -595M 3 614M 7 732M -1 455M -5 682M 12 738M -360M 372M 502M -3 320M
cashAtEndOfPeriod 18 231M 18 577M 24 105M 19 980M 24 878M 25 473M 21 859M 19 728M 21 183M 26 865M 14 127M 11 355M 14 487M 13 985M
cashAtBeginningOfPeriod 18 577M 38 474M 21 859M 24 878M 25 473M 21 859M 14 127M 21 183M 26 865M 14 127M 14 487M 10 983M 13 985M 17 305M
operatingCashFlow 9 169M 3 878M 24 266M 7 993M 5 633M 3 657M 22 791M 7 489M 4 182M 3 257M 21 194M 6 284M 23 410M 23 536M
capitalExpenditure -788M -1 398M -4 424M -2 279M -976M -807M -4 543M -967M -1 124M -863M -4 009M -952M -3 652M -3 347M
freeCashFlow 8 381M 2 480M 19 842M 5 714M 4 657M 2 850M 18 248M 6 522M 3 058M 2 394M 17 185M 5 332M 19 758M 20 189M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-13 2024-02-16 2023-02-16 2022-02-17 2021-02-22
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 235M -3 063M 65M 417M -1 203M
netCashProvidedByInvestingActivities -18 599M 878M -12 371M -8 683M -20 825M
netDebtIssuance 10 051M -2 734M 7 452M -990M 7 095M
longTermNetDebtIssuance 5 207M -1 551M -2 132M -1 797M 6 367M
shortTermNetDebtIssuance 4 844M -1 183M 9 584M 807M 728M
netStockIssuance -2 432M -813M -6 035M -3 456M -3 221M
netCommonStockIssuance -2 432M -813M -6 035M -3 456M -3 221M
commonStockIssuance 0 4 241M 0 0 0
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid -11 823M -11 770M -11 682M -11 032M -10 481M
commonDividendsPaid -11 823M -11 770M -11 682M -11 032M -10 481M
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 1 072M -508M 1 394M 1 431M 487M
netCashProvidedByFinancingActivities -3 132M -15 825M -8 871M -14 047M -6 120M
incomeTaxesPaid 6 714M 8 574M 5 223M 4 768M 4 619M
interestPaid 1 911M 1 766M 933M 941M 841M

Earning call transcript

2025 q4
2026-01-21 ET (fiscal 2025 q4)
2025 q3
2025-10-14 ET (fiscal 2025 q3)
2025 q2
2025-07-16 ET (fiscal 2025 q2)
2025 q1
2025-04-15 ET (fiscal 2025 q1)
2024 q4
2025-01-22 ET (fiscal 2024 q4)
2024 q3
2024-10-15 ET (fiscal 2024 q3)
2024 q2
2024-07-17 ET (fiscal 2024 q2)
2024 q1
2024-04-16 ET (fiscal 2024 q1)
2023 q4
2024-01-23 ET (fiscal 2023 q4)
2023 q3
2023-10-17 ET (fiscal 2023 q3)
2023 q2
2023-07-20 ET (fiscal 2023 q2)
2023 q1
2023-04-18 ET (fiscal 2023 q1)
2022 q4
2023-01-24 ET (fiscal 2022 q4)
2022 q3
2022-10-18 ET (fiscal 2022 q3)
2022 q2
2022-07-19 ET (fiscal 2022 q2)
2022 q1
2022-04-19 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2026-01-21 07:46 ET
Johnson & Johnson published news for 2025 q4
SEC form 8
2026-01-21 07:46 ET
Johnson & Johnson published news for 2025 q4
SEC form 8
2026-01-21 07:46 ET
Johnson & Johnson reported for 2025 q4
SEC form 10
2025-10-22 20:04 ET
Johnson & Johnson reported for 2025 q3
SEC form 8
2025-10-14 11:22 ET
Johnson & Johnson published news for 2025 q3
SEC form 8
2025-10-14 11:22 ET
Johnson & Johnson published news for 2025 q3
SEC form 8
2025-10-14 11:22 ET
Johnson & Johnson reported for 2025 q3
SEC form 8
2025-10-14 11:22 ET
Johnson & Johnson published news for 2025 q3
SEC form 10
2025-07-24 20:04 ET
Johnson & Johnson reported for 2025 q2
SEC form 8
2025-07-16 12:06 ET
Johnson & Johnson published news for 2025 q2
SEC form 8
2025-07-16 12:06 ET
Johnson & Johnson published news for 2025 q2
SEC form 8
2025-07-16 12:06 ET
Johnson & Johnson reported for 2025 q2
SEC form 10
2025-04-23 20:04 ET
Johnson & Johnson published news for 2025 q1
SEC form 10
2025-04-23 00:00 ET
Johnson & Johnson reported for 2025 q1
SEC form 8
2025-04-15 12:14 ET
Johnson & Johnson published news for 2025 q1
SEC form 8
2025-04-15 12:14 ET
Johnson & Johnson published news for 2025 q1
SEC form 8
2025-04-15 12:14 ET
Johnson & Johnson reported for 2025 q1
SEC form 8
2025-04-15 12:14 ET
Johnson & Johnson published news for 2025 q1
SEC form 8
2025-04-03 20:43 ET
Johnson & Johnson published news for 2025 q1
SEC form 8
2025-04-03 20:43 ET
Johnson & Johnson published news for 2025 q1
SEC form 8
2025-02-26 21:23 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-26 21:23 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-26 21:23 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-26 21:23 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-26 21:23 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-26 21:23 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-26 21:23 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-26 21:23 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-26 21:23 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-26 21:23 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-20 22:26 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-20 22:26 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-20 22:26 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-20 22:26 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-20 22:26 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-20 22:26 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-20 22:26 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-20 22:26 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-20 22:26 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-20 22:26 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-02-20 22:26 ET
Johnson & Johnson published news for 2024 q4
SEC form 10
2025-02-13 21:07 ET
Johnson & Johnson published news for 2024 q4
SEC form 10
2025-02-13 00:00 ET
Johnson & Johnson reported for 2024 q4
SEC form 8
2025-01-22 06:35 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-01-22 06:35 ET
Johnson & Johnson published news for 2024 q4
SEC form 8
2025-01-22 06:35 ET
Johnson & Johnson reported for 2024 q4
SEC form 10
2024-10-23 00:00 ET
Johnson & Johnson reported for 2024 q3
SEC form 8
2024-10-15 07:37 ET
Johnson & Johnson published news for 2024 q3
SEC form 8
2024-10-15 07:37 ET
Johnson & Johnson published news for 2024 q3
SEC form 8
2024-10-15 07:37 ET
Johnson & Johnson reported for 2024 q3
SEC form 10
2024-07-25 00:00 ET
Johnson & Johnson reported for 2024 q2
SEC form 8
2024-07-17 08:14 ET
Johnson & Johnson published news for 2024 q2
SEC form 8
2024-07-17 08:14 ET
Johnson & Johnson published news for 2024 q2
SEC form 8
2024-07-17 08:14 ET
Johnson & Johnson reported for 2024 q2
SEC form 10
2024-05-01 00:00 ET
Johnson & Johnson reported for 2024 q1
SEC form 8
2024-05-01 00:00 ET
Johnson & Johnson published news for 2024 q1
SEC form 8
2024-05-01 00:00 ET
Johnson & Johnson reported for 2024 q1
SEC form 8
2024-05-01 00:00 ET
Johnson & Johnson published news for 2024 q1
SEC form 8
2024-04-16 07:06 ET
Johnson & Johnson published news for 2024 q1
SEC form 8
2024-04-16 07:06 ET
Johnson & Johnson published news for 2024 q1
SEC form 8
2024-04-16 07:06 ET
Johnson & Johnson reported for 2024 q1
SEC form 8
2024-04-16 07:06 ET
Johnson & Johnson published news for 2024 q1
SEC form 10
2024-02-16 16:12 ET
Johnson & Johnson reported for 2023 q4
SEC form 10
2024-02-16 00:00 ET
Johnson & Johnson reported for 2023 q4
SEC form 8
2024-01-23 07:45 ET
Johnson & Johnson published news for 2023 q4
SEC form 8
2024-01-23 07:45 ET
Johnson & Johnson published news for 2023 q4
SEC form 8
2024-01-23 07:45 ET
Johnson & Johnson reported for 2023 q4
SEC form 10
2023-10-27 00:00 ET
Johnson & Johnson reported for 2023 q3
SEC form 8
2023-10-17 07:33 ET
Johnson & Johnson reported for 2023 q3
SEC form 8
2023-08-30 00:00 ET
Johnson & Johnson published news for 2023 q2
SEC form 10
2023-07-31 00:00 ET
Johnson & Johnson reported for 2023 q2
SEC form 6
2023-07-20 07:15 ET
Johnson & Johnson reported for 2023 q2
SEC form 8
2023-07-20 00:00 ET
Johnson & Johnson published news for 2023 q2
SEC form 6
2023-06-26 16:39 ET
Johnson & Johnson published news for 2023 q1
SEC form 6
2023-06-26 16:38 ET
Johnson & Johnson published news for 2023 q1
SEC form 10
2023-04-28 00:00 ET
Johnson & Johnson reported for 2023 q1
SEC form 6
2023-04-18 07:29 ET
Johnson & Johnson reported for 2023 q1
SEC form 8
2023-04-18 00:00 ET
Johnson & Johnson reported for 2023 q1
SEC form 6
2023-04-04 16:12 ET
Johnson & Johnson published news for 2023 q1
SEC form 6
2023-03-31 19:29 ET
Johnson & Johnson published news for 2022 q4
SEC form 10
2023-02-16 16:01 ET
Johnson & Johnson reported for 2022 q4
SEC form 10
2023-02-16 00:00 ET
Johnson & Johnson reported for 2022 q4
SEC form 6
2023-02-14 17:55 ET
Johnson & Johnson published news for 2022 q4
SEC form 6
2023-02-14 16:35 ET
Johnson & Johnson published news for 2022 q4
SEC form 6
2023-01-24 07:44 ET
Johnson & Johnson reported for 2022 q4
SEC form 8
2023-01-24 00:00 ET
Johnson & Johnson reported for 2022 q4
SEC form 6
2022-12-22 16:31 ET
Johnson & Johnson published news for 2022 q3
SEC form 6
2022-11-30 17:38 ET
Johnson & Johnson published news for 2022 q3
SEC form 6
2022-11-01 07:30 ET
Johnson & Johnson published news for 2022 q3
SEC form 10
2022-10-27 16:02 ET
Johnson & Johnson reported for 2022 q3
SEC form 10
2022-10-27 00:00 ET
Johnson & Johnson reported for 2022 q3
SEC form 6
2022-10-18 07:54 ET
Johnson & Johnson published news for 2022 q3
SEC form 8
2022-10-18 00:00 ET
Johnson & Johnson reported for 2022 q3
SEC form 6
2022-09-14 07:10 ET
Johnson & Johnson published news for 2022 q2
SEC form 10
2022-07-29 16:14 ET
Johnson & Johnson reported for 2022 q2
SEC form 10
2022-07-29 00:00 ET
Johnson & Johnson reported for 2022 q2
SEC form 6
2022-07-19 07:59 ET
Johnson & Johnson published news for 2022 q2
SEC form 8
2022-07-19 00:00 ET
Johnson & Johnson reported for 2022 q2
SEC form 6
2022-06-16 16:33 ET
Johnson & Johnson published news for 2022 q1
SEC form 6
2022-06-16 16:31 ET
Johnson & Johnson published news for 2022 q1
SEC form 10
2022-04-29 16:08 ET
Johnson & Johnson reported for 2022 q1
SEC form 6
2022-04-29 16:03 ET
Johnson & Johnson published news for 2022 q1
SEC form 10
2022-04-29 00:00 ET
Johnson & Johnson reported for 2022 q1
SEC form 6
2022-04-19 07:56 ET
Johnson & Johnson published news for 2022 q1
SEC form 8
2022-04-19 00:00 ET
Johnson & Johnson reported for 2022 q1
SEC form 6
2022-03-16 08:10 ET
Johnson & Johnson published news for 2021 q4
SEC form 10
2022-02-17 16:06 ET
Johnson & Johnson published news for 2021 q4
SEC form 10
2022-02-17 00:00 ET
Johnson & Johnson published news for 2021 q4
SEC form 6
2022-02-15 18:07 ET
Johnson & Johnson published news for 2021 q4
SEC form 6
2022-02-02 16:35 ET
Johnson & Johnson published news for 2021 q4
SEC form 6
2022-01-25 08:00 ET
Johnson & Johnson published news for 2021 q4
SEC form 8
2022-01-25 00:00 ET
Johnson & Johnson published news for 2021 q4
SEC form 6
2022-01-06 16:51 ET
Johnson & Johnson published news for 2021 q4
SEC form 6
2021-11-15 16:57 ET
Johnson & Johnson published news for 2021 q3
SEC form 10
2021-10-29 16:05 ET
Johnson & Johnson published news for 2021 q3
SEC form 10
2021-10-29 00:00 ET
Johnson & Johnson published news for 2021 q3
SEC form 6
2021-10-19 08:01 ET
Johnson & Johnson published news for 2021 q3
SEC form 8
2021-10-19 00:00 ET
Johnson & Johnson published news for 2021 q3
SEC form 6
2021-10-12 16:50 ET
Johnson & Johnson published news for 2021 q3
SEC form 6
2021-08-20 16:31 ET
Johnson & Johnson published news for 2021 q2
SEC form 10
2021-07-29 16:07 ET
Johnson & Johnson published news for 2021 q2
SEC form 10
2021-07-29 00:00 ET
Johnson & Johnson published news for 2021 q2
SEC form 6
2021-07-21 08:00 ET
Johnson & Johnson published news for 2021 q2
SEC form 8
2021-07-21 00:00 ET
Johnson & Johnson published news for 2021 q2
SEC form 6
2021-06-17 16:48 ET
Johnson & Johnson published news for 2021 q1
SEC form 6
2021-06-17 16:40 ET
Johnson & Johnson published news for 2021 q1
SEC form 6
2021-06-01 17:16 ET
Johnson & Johnson published news for 2021 q1
SEC form 10
2021-04-30 16:04 ET
Johnson & Johnson published news for 2021 q1
SEC form 10
2021-04-30 00:00 ET
Johnson & Johnson published news for 2021 q1
SEC form 6
2021-04-26 16:35 ET
Johnson & Johnson published news for 2021 q1
SEC form 6
2021-04-20 08:02 ET
Johnson & Johnson published news for 2021 q1
SEC form 8
2021-04-20 00:00 ET
Johnson & Johnson published news for 2021 q1
SEC form 6
2021-03-10 08:21 ET
Johnson & Johnson published news for 2020 q4
SEC form 10
2021-02-22 16:36 ET
Johnson & Johnson published news for 2020 q4
SEC form 6
2021-01-26 08:06 ET
Johnson & Johnson published news for 2020 q4
SEC form 6
2020-12-03 16:47 ET
Johnson & Johnson published news for 2020 q3
SEC form 6
2020-11-03 16:45 ET
Johnson & Johnson published news for 2020 q3
SEC form 10
2020-10-23 16:06 ET
Johnson & Johnson published news for 2020 q3
SEC form 6
2020-10-13 07:12 ET
Johnson & Johnson published news for 2020 q3
SEC form 6
2020-10-01 16:22 ET
Johnson & Johnson published news for 2020 q3